Clinical trial

Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer

NCT00009971

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-11-01

PhasePHASE2

Study timeline

Study start (unknown)2000-11-01Date precision: month

Registry last updated2013-02-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

fenretinideDRUG

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

DetroitMichigan, United States1 Ann ArborMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00009971 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.